Patents by Inventor Azra S. Zaidi

Azra S. Zaidi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Erythrocyte sedimentation rate control
    Patent number: 6342391
    Abstract: A three-phase suspension suitable for use as an erythrocyte sedimentation rate (ESR) control having the following three components: (1) a synthetic plasma base, (2) an aggregating agent such as a high molecular weight polymer or combination of high molecular weight polymers, and (3) chemically fixed mammalian red blood cells. The control is designed to allow the user to monitor the accuracy and precision of analytical methods for determining the sedimentation rate of human erythrocytes in whole blood specimens. Chemical fixing of the red blood cells provides the ESR control with the capability of providing useful results in the presence of citrate and/or saline.
    Type: Grant
    Filed: October 12, 1999
    Date of Patent: January 29, 2002
    Assignees: Streck Laboratories, Inc., Hematronix Inc.
    Inventors: Roulhwai Chen, Azra S. Zaidi
  • Erythrocyte sedimentation rate control
    Patent number: 6017764
    Abstract: A three-phase suspension suitable for use as an erythrocyte sedimentation rate (ESR) control having the following three components: (1) a synthetic plasma base, (2) an aggregating agent such as a high molecular weight polymer or combination of high molecular weight polymers, and (3) chemically fixed mammalian red blood cells. The control is designed to allow the user to monitor the accuracy and precision of analytical methods for determining the sedimentation rate of human erythrocytes in whole blood specimens. Chemical fixing of the red blood cells provides the ESR control with the capability of providing useful results in the presence of citrate and/or saline.
    Type: Grant
    Filed: April 20, 1999
    Date of Patent: January 25, 2000
    Assignees: Streck Laboratories, Inc., Hematronix, Inc.
    Inventors: Roulhwai Chen, Azra S. Zaidi
  • Erythrocyte sedimentation rate control
    Patent number: 5895760
    Abstract: A three-phase suspension suitable for use as an erythrocyte sedimentation rate (ESR) control having the following three components: (1) a synthetic plasma base, (2) an aggregating agent such as a high molecular weight polymer or combination of high molecular weight polymers, and (3) chemically fixed mammalian red blood cells. The control is designed to allow the user to monitor the accuracy and precision of analytical methods for determining the sedimentation rate of human erythrocytes in whole blood specimens. Chemical fixing of the red blood cells provides the ESR control with the capability of providing useful results in the presence of citrate and/or saline.
    Type: Grant
    Filed: February 4, 1997
    Date of Patent: April 20, 1999
    Assignee: Hycor Biomedical, Inc.
    Inventors: Roulhwai Chen, Azra S. Zaidi